• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC MEXICO SPRINTER LEGEND RX; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC MEXICO SPRINTER LEGEND RX; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Ischemia (1942)
Event Date 10/21/2016
Event Type  Death  
Manufacturer Narrative
Literature reference: dx.Doi.Org/10.1016/j.Wneu.2016.1064.If information is provided in the future, a supplemental report will be issued.
 
Event Description
From journal article: the safety and efficacy of noncompliant balloon angioplasty was reported for treatment of subarachnoid haemorrhage-induced cerebral vasospasm at three major academic institutions in the united states.Vessels treated include the internal carotid artery (ica), middle cerebral artery (mca), anterior cerebral artery (aca), basilar artery (ba), posterior cerebral artery (pca), posterior inferior cerebellar artery (pica) and vertebral artery (va).Aneurysmal subarachnoid haemorrhage (sah) was present in 50 patients, whereas the sah was from an unknown source in 2 patients.The sprinter legend balloon was the most commonly used balloon during the angioplasty procedures.During the procedure, the balloon was inflated to nominal pressure at a rate of 2-4 atm per minute using a manual insufflation device and repositioned after deflation as needed.All procedures used noncompliant balloons.The mca and intracranial ica were the most commonly treated vessels.No procedure related complications were reported.There was improvement in angiographic vasospasm in 97% of cases without any associated procedural morbidity or mortality.Outcome included delayed cerebral ischemia.Functional outcome after discharge from icu included patient death.One patient presented with a ruptured anterior choroidal internal carotid artery aneurysm, which was subsequently treated with endovascular embolization.The procedure was complicated by thrombosis of the right anterior cerebral and middle cerebral arteries, which was treated with medical thrombolysis and mechanical thrombectomy.The patient developed significant cerebral edema of the right hemisphere and underwent hemicraniectomy.On hospital day 4, the patient had a decline in mental status and was taken for digital subtraction angiography.Angiographic vasospasm was found in the right m1 segment of the middle cerebral artery and right a1 segment of the anterior cerebral artery.Angioplasty was performed with a sprinter legend balloon (1.5 mm x 10 mm) in the right m1 segment, and intra-arterial verapamil was infused in both right m1 and a1 segments.Vasospasm of the right m1 segment improved from severe to moderate.The patient¿s clinical condition remained poor, and the patient died on hospital day 10.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPRINTER LEGEND RX
Type of Device
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
MEDTRONIC MEXICO
av. paseo del cucapah #10510
tijuana,bc 22570
MX  22570
Manufacturer (Section G)
MEDTRONIC MEXICO
av. paseo del cucapah #10510
tijuana,bc 22570
MX   22570
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key7343533
MDR Text Key102569192
Report Number9612164-2018-00519
Device Sequence Number1
Product Code LOX
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P790017
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date 10/04/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/16/2018
Initial Date FDA Received03/15/2018
Supplement Dates Manufacturer Received07/19/2018
08/08/2018
Supplement Dates FDA Received07/19/2018
10/04/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age59 YR
-
-